Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-of-1 trial of levothyroxine plus liothyronine versus levothyroxine plus placebo in symptomatic hypothyroidism
ACTRN12622000106730Phase 4Not yet recruiting
- Sponsor
- The University of Auckland
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levothyroxine sodium and liothyronine in hypothyroidism (2 arms), sponsored by The University of Auckland. Primary endpoint: Difference in hypothyroidism-specific quality of life. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
levothyroxine sodiumliothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on ACTRN12622000106730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000106730.